Prescription drug · ANDA
Aprepitant NDC 68001-668
Aprepitant 125 mg/1 · Capsule · Oral · BluePoint Laboratories
NDC codes
FDA NDC Directory| Package NDC | 11-digit (billing) | Package | Copy |
|---|---|---|---|
| 68001-668-19 | 6800106681968001066819 | 1 BLISTER PACK in 1 CARTON (68001-668-19) / 6 CAPSULE in 1 BLISTER PACK (68001-668-44)Marketed from Feb 10, 2026 |
How the 11-digit form is made: The product segment has 3 digits, so one leading zero is added to it (5-3-2 → 5-4-2). Formatting the NDC does not by itself make it billable — the product, package and quantity must match what was dispensed or administered, and payer rules apply. Conversion rules
Product information
- Brand name (proprietary)
- Aprepitant
- Generic name (nonproprietary)
- aprepitant
- Active ingredients
- Aprepitant — 125 mg/1
- Dosage form
- Capsule
- Route
- Oral
- Labeler
- BluePoint LaboratoriesNDC labeler code 68001
- Product type
- Prescription drug
- Marketing category
- ANDA — Abbreviated New Drug Application (generic)Application ANDA 207777
- Marketing start
- Listing expires
- Other FDA classes
- Cytochrome P450 2C9 Inducers (Mechanism)Cytochrome P450 3A4 Inducers (Mechanism)Cytochrome P450 3A4 Inhibitors (Mechanism)Neurokinin 1 Antagonists (Mechanism)
- Identifiers
- Product ID 68001-668_4e00638d-1cbc-f20f-e063-6294a90ac14cSPL ID 4e00638d-1cbc-f20f-e063-6294a90ac14cSPL set ID a78aaa00-a46b-4f9e-a415-2fca9e9a4fb4RxCUI 403810, 403811, 644088, 754508UNII 1NF15YR6UYUPC 0368001669153
- Pharmacologic class
- Substance P/Neurokinin-1 Receptor Antagonist
Billing references
What Med-Code can say about coding this product, and where each statement comes from. Nothing here is inferred from the name alone.
- HCPCS codeNo match
No HCPCS code in Med-Code's directory. Oral products like this are usually dispensed by a pharmacy and billed by NDC.
- NDC on a medical claim
N468001066819followed by a unit qualifier and the quantityPackage 68001-0668-19. Unit qualifiers: F2 (international unit), GR (gram), ME (milligram), ML (milliliter), UN (unit (each)). The qualifier and quantity depend on what was given. About the N4 qualifier
Product label
Current FDA label (SPL), effective .
Indications (excerpt from the label)
Aprepitant is a substance P/neurokinin 1 (NK 1 ) receptor antagonist. Aprepitant capsules are indicated in combination with other antiemetic agents, in patients 12 years of age and older for prevention of: acute and delayed nausea and vomiting associated with initial and repeat courses of highly emetogenic cancer chemotherapy (HEC) including high-dose cisplatin ( 1.1 ) nausea and vomiting associated with initial and repeat courses of moderately emetogenic cancer chemotherapy (MEC) ( 1.1 ) for prevention of postoperative nausea and vomiting (PONV) in adults ( 1.2 ) Limitations of Use : ( 1.3 ) Aprepitant has not been studied for treatment of established nausea and vomiting. Chronic continuous…
Excerpt only. Read the full label for complete information.
About NDC 68001-668
- What is NDC 68001-668?
- 68001-668 is the product NDC for Aprepitant, Aprepitant 125 mg/1 capsule, listed with the FDA by BluePoint Laboratories. It has 1 package NDC, shown above in 10- and 11-digit form.
- What drug is associated with this NDC?
- Aprepitant.
- What is the active ingredient?
- Aprepitant.
- Who is the labeler?
- BluePoint Laboratories, NDC labeler code 68001. The labeler is the company responsible for the label; it may be the manufacturer, a repackager or a distributor.
- What other NDCs exist for Aprepitant?
- 19 other product NDCs are listed under this name. See all Aprepitant NDCs.
- Is there a related HCPCS / J-code?
- Not in Med-Code's curated HCPCS directory. See Billing references above.
Related NDCs: other Aprepitant products
Other finished products listed under the same name: strengths, forms and labelers.
| Product | Strength | Form · route | Labeler | Product NDC | Package NDCs (11-digit) |
|---|---|---|---|---|---|
| Aprepitant | — | Kit | BluePoint Laboratories | 68001-669 | 68001-0669-15 |
| Aprepitant | Aprepitant 40 mg/1 | CapsuleOral | BluePoint Laboratories | 68001-666 | 68001-0666-0168001-0666-17 |
| Aprepitant | Aprepitant 80 mg/1 | CapsuleOral | BluePoint Laboratories | 68001-667 | 68001-0667-0168001-0667-19 |
| Aprepitant | Aprepitant 40 mg/1 | CapsuleOral | Torrent Pharmaceuticals Limited | 13668-591 | 13668-0591-8113668-0591-82 |
| Aprepitant | Aprepitant 80 mg/1 | CapsuleOral | Torrent Pharmaceuticals Limited | 13668-592 | 13668-0592-8413668-0592-86 |
| Aprepitant | Aprepitant 125 mg/1 | CapsuleOral | Torrent Pharmaceuticals Limited | 13668-593 | 13668-0593-86 |
| Aprepitant | — | Kit | Torrent Pharmaceuticals Limited | 13668-594 | 13668-0594-87 |
| Aprepitant | Aprepitant 40 mg/1 | CapsuleOral | Golden State Medical Supply, Inc. | 51407-701 | 51407-0701-0151407-0701-05 |
| Aprepitant | Aprepitant 80 mg/1 | CapsuleOral | Golden State Medical Supply, Inc. | 51407-702 | 51407-0702-0251407-0702-06 |
| Aprepitant | Aprepitant 125 mg/1 | CapsuleOral | Golden State Medical Supply, Inc. | 51407-703 | 51407-0703-06 |
Other NDCs under ANDA 207777
Products listed under the same FDA application: other strengths and forms, and repackagers who relabel the same product.
| Product | Strength | Form · route | Labeler | Product NDC |
|---|---|---|---|---|
| Aprepitant | Aprepitant 40 mg/1 | CapsuleOral | BluePoint Laboratories | 68001-666 |
| Aprepitant | Aprepitant 80 mg/1 | CapsuleOral | BluePoint Laboratories | 68001-667 |
| Aprepitant | — | Kit | BluePoint Laboratories | 68001-669 |
| Aprepitant | — | Kit | Glenmark Pharmaceuticals Inc., USA | 68462-112 |
| Aprepitant | Aprepitant 40 mg/1 | CapsuleOral | Glenmark Pharmaceuticals Inc., USA | 68462-583 |
| Aprepitant | Aprepitant 80 mg/1 | CapsuleOral | Glenmark Pharmaceuticals Inc., USA | 68462-584 |
| Aprepitant | Aprepitant 125 mg/1 | CapsuleOral | Glenmark Pharmaceuticals Inc., USA | 68462-585 |